美国青少年及其家长对COVID-19疫苗接种的接受度调查
2021年4月15-23日,在FDA扩大辉瑞-BioNTech COVID-19疫苗紧急使用授权至12-15岁青少年之前,通过非概率网络面板调查了985名13-17岁青少年和1022名12-17岁青少年的家长。结果显示,已符合接种条件的16-17岁青少年中约四分之一已接种至少一剂;未接种青少年中约半数家长和青少年表示愿意接种;疫苗安全性和有效性信息及学校接种要求是提高接种意愿的主要因素。
要点
- 已符合接种条件的16-17岁青少年中,家长报告27.6%已接种至少一剂,青少年自报26.1%。
- 未接种青少年中,55.5%家长和51.7%青少年表示肯定或可能会接种COVID-19疫苗。
- 获取更多疫苗安全性和有效性信息及学校接种要求是最常报告的提高接种意愿的因素。
核心结论
- 在疫苗授权前,约半数未接种青少年及其家长对青少年COVID-19疫苗接种持接受态度。
研究设计与样本
- 非概率网络面板调查,于2021年4月15-23日独立招募985名13-17岁青少年和1022名12-17岁青少年的家长。
主要发现
- 已符合接种条件的16-17岁青少年中,27.6%的家长报告其青少年已接种至少一剂COVID-19疫苗,青少年自报比例为26.1%。
- 未接种的12-17岁青少年家长中,55.5%表示肯定或可能会让青少年接种COVID-19疫苗。
- 未接种的13-17岁青少年中,51.7%表示肯定或可能会接种COVID-19疫苗。
- 家长和青少年均报告,获取更多关于青少年COVID-19疫苗安全性和有效性的信息以及学校COVID-19疫苗接种要求是最常提高接种意愿的因素。
- 联邦、州和地方卫生官员及初级保健专业人员是两组人群最信任的COVID-19疫苗信息来源。
临床怎么用
- 卫生官员和初级保健专业人员应重点向公众清晰传达青少年COVID-19疫苗接种的获益和安全性,以提高疫苗信心和接种覆盖率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
On May 10, 2021, the Food and Drug Administration (FDA) expanded its Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine to include adolescents aged 12-15 years; this authorization was followed by interim recommendations from the Advisory Committee on Immunization Practices (ACIP) for the vaccine among this age group (1). Using data from nonprobability-based Internet panel surveys administered by the Healthcare and Public Perceptions of Immunizations (HaPPI) Survey Collaborative, the acceptability of adolescent COVID-19 vaccination and self-reported factors increasing vaccination intent were assessed among independently recruited samples of 985 adolescents aged 13-17 years and 1,022 parents and guardians (parents) of adolescents aged 12-17 years during April 15-April 23, 2021, prior to vaccine authorization for this age group. Approximately one quarter (27.6%) of parents whose adolescents were already vaccine-eligible (i.e., aged 16-17 years) reported their adolescent had received ≥1 COVID-19 vaccine dose, similar to the proportion reported by vaccine-eligible adolescents aged 16-17 years (26.1%). However, vaccine receipt reported by parents of adolescents differed across demographic groups; parents identifying as female or Hispanic, or who had an education lower than a bachelor's degree reported the lowest adolescent COVID-19 vaccination receipt. Among parents of unvaccinated adolescents aged 12-17 years, 55.5% reported they would "definitely" or "probably" have their adolescent receive a COVID-19 vaccination. Among unvaccinated adolescents aged 13-17 years, 51.7% reported they would "definitely" or "probably" receive a COVID-19 vaccination. Obtaining more information about adolescent COVID-19 vaccine safety and efficacy, as well as school COVID-19 vaccination requirements, were the most commonly reported factors that would increase vaccination intentions among both parents and adolescents. Federal, state, and local health officials and primary care professionals were the most trusted sources of COVID-19 vaccine information among both groups. Efforts focusing on clearly communicating to the public the benefits and safety of COVID-19 vaccination for adolescents, particularly by health care professionals, could help increase confidence in adolescent COVID-19 vaccine and vaccination coverage.
引用
- Scherer AM, Gedlinske AM, Parker AM, et al. Acceptability of Adolescent COVID-19 Vaccination Among Adolescents and Parents of Adolescents - United States, April 15-23, 2021. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34264908. doi:10.15585/mmwr.mm7028e1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。